NEW YORK, March 24, 2016 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of DS Healthcare Group, Inc. ("DS Healthcare" or "the Company") (NASDAQ: DSKX). Such investors are advised to contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz at email@example.com or 212-697-6484.
This investigation concerns whether DS Healthcare and certain of its officers and/or directors have violated the Federal Securities Laws under the Securities Exchange Act of 1934 (the "Exchange Act").
On March 23, 2016, post-market, DS Healthcare revealed that its financial statements for the two fiscal quarters ended June 30, 2015 and September 30, 2015 were found to have revenue recognition errors and improper recording of certain equity transactions and therefore, should no longer be relied upon. DS Healthcare has reviewed these issues with its Audit Committee and independent accounting firm, and said it will restate the relevant financial statements as soon as possible. DS Healthcare also announced that the Audit Committee and independent counsel had started an investigation in connection with the company's President, Daniel Khesin, for allegedly fraudulent revenue recognition and equity transaction errors and that Mr. Khesin had been dismissed.
Following this news, DS Healthcare stock has fallen as much as $0.68, or 51.13%, to $0.65 during intraday trading on March 24, 2016.
If you are aware of any facts relating to this investigation, or purchased shares of DS Healthcare, you can assist this investigation by visiting the firm's website: http://www.bgandg.com/#!dskx/ozv6l. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-ds-healthcare-group-inc-dskx-300241283.html
SOURCE Bronstein, Gewirtz & Grossman, LLC